Galectin-3, new potential therapeutic target for cardiac remodelling. [electronic resource]
- European journal of heart failure Jun 2013
- 709 p. digital
Publication Type: Letter; Comment
1879-0844
10.1093/eurjhf/hft055 doi
Angiotensin II Type 1 Receptor Blockers--therapeutic use Female Galectin 3--blood Heart Failure--blood Humans Male Tetrazoles--therapeutic use Valine--analogs & derivatives